PROCEPT BioRobotics EVP discloses initial holdings
PROCEPT BioRobotics Corp executive Barry L. Templin, EVP and Chief Technology Officer, filed an initial ownership report showing his equity stake in the company.
Rhea-AI Filing Summary
PROCEPT BioRobotics Corp executive Barry L. Templin, EVP and Chief Technology Officer, filed an initial ownership report showing his equity stake in the company. The filing lists 69,311 shares of Common Stock held directly and 56,457 shares held indirectly through the Templin Trust.
It also details several stock options to buy Common Stock, including 29,615 underlying shares at an exercise price of $25.35 per share expiring in 2036 and 34,591 underlying shares at $5.18 per share expiring in 2030. Footnotes describe these as time‑vested grants with monthly vesting schedules tied to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
Templin Barry L
Role
EVP, Chief Technology Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 161,663 contracts (Direct);
Common Stock — 69,311 shares (Direct);
Common Stock — 56,457 shares (Indirect, Barry L Templin and Katrina L. Templin, Trustees of the Templin Trust dated February 3, 2020)
Footnotes (6)
- F1. These securities include restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on the anniversary of the grant date, with one-twelfth of the remaining RSUs shall vest on each quarter thereafter, subject to the Reporting Person continuing as a service provider through such date.
- F2. The Stock Option is fully vested and exercisable.
- F3. The Stock Option was granted on 2/16/2023, and 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2023, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date
- F4. The Stock Option was granted on March 6, 2024 and 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2024, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date
- F5. The Stock Option was granted on March 3, 2025, and 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date
- F6. The Stock Option was granted on March 5, 2026, and 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date
Key Figures
Direct common stock holdings: 69,311 shares
Indirect common stock holdings (Templin Trust): 56,457 shares
Option at $25.35: 29,615 underlying shares at $25.35/share
+5 more
8 metrics
Direct common stock holdings
69,311 shares
Common Stock held directly after reporting
Indirect common stock holdings (Templin Trust)
56,457 shares
Common Stock held indirectly through Templin Trust
Option at $25.35
29,615 underlying shares at $25.35/share
Stock Option (Right to Buy), expiration 2036-03-04
Option at $60.60
14,388 underlying shares at $60.60/share
Stock Option (Right to Buy), expiration 2035-03-02
Option at $37.02
26,253 underlying shares at $37.02/share
Stock Option (Right to Buy), expiration 2033-02-15
Option at $7.27
19,999 underlying shares at $7.27/share
Stock Option (Right to Buy), expiration 2031-06-21
Option at $5.18
34,591 underlying shares at $5.18/share
Stock Option (Right to Buy), expiration 2030-08-09
RSU vesting structure
1/4 at anniversary, then quarterly
RSUs vest over time, contingent on continued service
Key Terms
restricted stock units (RSUs), Stock Option (Right to Buy), exercise price, expiration date, +2 more
6 terms
restricted stock units (RSUs) financial
"These securities include restricted stock units (RSUs). Each RSU represents a contingent right to receive one share"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
exercise price financial
""conversion_or_exercise_price": "25.3500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
""expiration_date": "2036-03-04T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"shall vest monthly from the vesting commencement date of March 5, 2023, over a four year period"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
indirect ownership financial
"ownership_type": "indirect""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the PROCEPT BioRobotics (PRCT) Form 3 filing show for Barry L. Templin?
The Form 3 filing shows EVP and Chief Technology Officer Barry L. Templin’s existing ownership. He directly holds 69,311 PROCEPT BioRobotics Common Stock shares and indirectly holds 56,457 shares through the Templin Trust, establishing his baseline equity position as an executive.
What stock options are reported for Barry Templin in the PROCEPT BioRobotics (PRCT) Form 3?
The filing lists several stock options to buy PROCEPT BioRobotics Common Stock, including 29,615 underlying shares at $25.35, 14,388 at $60.60, 16,835 at $47.17, 26,253 at $37.02, 19,982 at $34.99, 19,999 at $7.27, and 34,591 at $5.18 per share.
When do Barry Templin’s PROCEPT BioRobotics (PRCT) stock options expire?
The reported stock options have staggered expiration dates, including options expiring on 2036-03-04, 2035-03-02, 2034-03-05, 2033-02-15, 2032-03-30, 2031-06-21, and 2030-08-09. These expirations define how long Templin can exercise each grant.
How do Barry Templin’s stock options in PROCEPT BioRobotics (PRCT) vest?
Footnotes state that certain stock options were granted annually and vest monthly over four years. For example, options granted in 2023, 2024, 2025, and 2026 vest at 1/48th of the shares each month, contingent on Templin’s continued employment or service with PROCEPT BioRobotics.
What are the restricted stock units (RSUs) mentioned in Barry Templin’s PROCEPT BioRobotics (PRCT) filing?
The filing explains that some reported securities include restricted stock units, each representing a right to receive one PROCEPT BioRobotics share. One-quarter of the RSUs vest on the grant anniversary, with the remaining three-quarters vesting in equal quarterly installments, subject to continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
